![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
Advertisement
Persons > All
Find below all kinds of persons.Total search results: 6658 | Ordered by Person (ascending)
1 2 3 ... 10 11 12 ... 65 66 67 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| Coppard, Nicholas (Santhera 201502– appointed SVP Head Development) | Research & Development Manager | Santhera (Group) | Switzerland |
| Coquoz, Didier (Oncalis 200810 CEO) | Chief Executive Officer (CEO) | Oncalis AG | Switzerland |
| Corazza, Sabrina (Axxam 201603 Director Business Development) | Business Development Manager / Strategy Manager | Axxam S.p.A. | Italy |
| Corbett, Jim (PerkinElmer 201207 President Diagnostics) | President/Director/Head Business Group/Unit/Division | PerkinElmer (Group) | United States (USA) |
| Cordes, Ralf (Ascienion 200902 Technology Manager) | IP Manager | Helmholtz-Gemeinschaft (HGF) (Group) | Germany |
| Cordes, Ulrik (Biocartis 201309– CCO before Thermo Fisher + Dako A/S + Pharmacia Biotech A/S) | Chief Commercial Officer (CCO) | Biocartis (Group) | Switzerland |
| Cornett, Shannon (Bruker 201305 Applications Developm Manager) | Research & Development Manager | Bruker Corporation (Group) | United States (USA) |
| Corr, David (EKF Diagnostics 201307– CTO before Head of RnD) | Chief Technology/Technical Officer (CTO) | EKF Diagnostics (Group) | United Kingdom (GB) |
| Corr, Peter B. (Celtic Therapeutics 2007 Managing General Partner + Co-Founder) | General Partner (venture partner) | Auven Therapeutics (Group) | United States (USA) |
| Corriveau, Jacques (AstraZeneca 201711– General Manager North America at Definiens) | General Manager (management) | AstraZeneca (Group) | United States (USA) |
| Corsico, Christopher (Boehringer 201708 CMO) | Chief Medical Officer (CMO) | Boehringer Ingelheim (Group) | Germany |
| Cortese, Riccardo (Nouscom 201605 CEO + Co-Founder before Okairos CEO + co-founder) | Chief Executive Officer (CEO) | Nouscom (Group) | Switzerland |
| Corvaïa, Nathalie (Pierre Fabre 201404 Managing Director of Center of Immunology Pierre Fabre) | Managing Director | Pierre Fabre (Group) | France |
| Cospedal, Rosario (Zeltia 201211 CEO of Genomica S.A.U.) | Chief Executive Officer (CEO) | PharmaMar (Group) | Spain (España) |
| Costantin, James (Nanion 201807 Director Customer Relations located at US West Coast Office) | Sales Manager / Marketing Manager | Nanion (Group) | United States (USA) |
| Costantini, Dominique (OSE Pharma 201504 CEO + Co-founder + former CEO + Co-founder of BioAlliance Pharma in 1997) | Chief Executive Officer (CEO) | OSE Immunotherapeutics (Group) | France |
| Cotte, Yann (Nanolive 201602 Managing Director) | Managing Director | Nanolive S.A. | Switzerland |
| Cottier, Gilles (Sigma-Aldrich 201004 President SAFC) | President/Director/Head Business Group/Unit/Division | Merck (DE) (Group) | United States (USA) |
| Cottier, Gilles (Sigma-Aldrich 201504 EVP + President SAFC Commercial) | President/Director/Head Business Group/Unit/Division | Merck (DE) (Group) | United States (USA) |
| Couch, Gregory (Radimetrics 2009– CEO + Founder) | Chief Executive Officer (CEO) | Bayer (Group) | Canada |
| Coucke, Marc (Alychlo before Omega Pharma 1987– CEO + Founder) | Chief Executive Officer (CEO) | Alychlo (Marc Coucke) | |
| Coukos, George (Univ Lausanne 201601 Prof + Director of Ludwig Institute for Cancer Research) | Professor | University of Lausanne (UNIL) | Switzerland |
| Coulter, Bianca (Coulter Partners 201711 CEO) | Chief Executive Officer (CEO) | Coulter Partners (The Coulter Partnership Ltd.) | United Kingdom (GB) |
| Courtine, Grégoire (EPFL + CHUV 201604 + G-Therapeutics 201604 CSO + Co-Founder) | Professor | EPFL (Ecole Polytechnique Fédérale de Lausanne) | Switzerland |
| Coutanceau, Emmanuelle (Novo Group 201705 Novo Seeds before Auriga Partners) | Investment Manager | Novo Group (Group) | Denmark |
| Coutet, Matthieu (Advent France Biotechnology 201704 Managing Partner before Inserm Transfert) | Managing Partner (investment firm) | Advent France Biotechnology S.A.S. | France |
| Couttie, John (Peak Scientific 201310 General Manager Americas) | General Manager (management) | Peak Scientific (Group) | United States (USA) |
| Cowan, Chad (CRISPR Therapeutics 201705 Head of Research) | Researcher (industry) | CRISPR Therapeutics (Group) | Switzerland |
| Cowan, David (Univ London 1990– Professor + Director Drug Control Centre King’s College) | Professor | University of London | United Kingdom (GB) |
| Cowling, Didier (Kuros 200807 CEO) | Chief Executive Officer (CEO) | Kuros (Group) | Switzerland |
| Cox, Jürgen (Max Planck 200705 MPI for Biochemistry) | n. a. | Max Planck Society for the Advancement of Science | Germany |
| Cox, Russ (Jazz Pharmaceuticals 201707 EVP + COO) | Chief Operating Officer (COO) | Jazz Pharmaceuticals plc (Nasdaq: JAZZ) | Ireland, Republic of |
| Cox, Steve | n. a. | Commerzbank (Group) | Germany |
| Craft, Noah (Science 37 201703 CEO + Co-Founder) | Chief Executive Officer (CEO) | Science 37 Inc. | United States (USA) |
| Craig, Frank (Sphere Fluidics 201711 CEO) | Chief Executive Officer (CEO) | Sphere Fluidics (Group) | United Kingdom (GB) |
| Cramer, Patrick (LMU 201201 Professor + since 2004 Director of LMU Gene Center Munich) | Professor | LMU Munich (Ludwig-Maximilians-Universität München) | Germany |
| Crawford, Bill (Roche 201112 Director of Marketing, Discovery at Ventana) | Sales Manager / Marketing Manager | Roche (Group) | United States (USA) |
| Creasey, Theresa S. (Sigma-Aldrich 201411 VP Diagnostics + Testing of Applied Business Unit) | President/Director/Head Business Group/Unit/Division | Merck (DE) (Group) | United States (USA) |
| Cresswell, Warren (Nestlé 201707 General Manager + Head of Prometheus Diagnostics + CEO of MDP) | Chief Executive Officer (CEO) | Nestlé (Group) | United States (USA) |
| Crook, Jayne (Instinctif Partners 201603) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | United Kingdom (GB) |
| Crooke, Stanley T. (Isis Pharmaceuticals 200604 CEO) | Chief Executive Officer (CEO) | Ionis Pharmaceuticals (Group) | United States (USA) |
| Crowe, Joanne (MorphoSys AbD –200603– Head Sales + Marketing) | Sales Manager / Marketing Manager | Bio-Rad (Group) | Germany |
| Crowley, Erin (Q Laboratories 201802 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Q Laboratories Inc. | United States (USA) |
| Crutchfield, Brad (Qiagen 201506–2016 SVP before Illumina + NanoString + Bio-Rad STEPPED DOWN 2016) | President/Director/Head Business Group/Unit/Division | Qiagen (Group) | Netherlands |
| Ctortecka, Bernd (Max Planck 200908 Patent + License Manager Max Planck Innovation GmbH) | IP Manager | Max Planck Society for the Advancement of Science | Germany |
| Cullmann, Hans (Comicon GmbH 201101 Managing Director + Founder + 45% Owner) | Managing Director | Endress+Hauser (Group) | Germany |
| Culp, H. Lawrence, Jr. (Danaher 2001–201502 CEO RETIRED 3/15) | Chief Executive Officer (CEO) | Danaher (Group) | United States (USA) |
| Cunha, Fernando (AB2 Bio 201602 CFO) | Chief Financial Officer (CFO) | AB2 Bio Ltd. (CH) | Switzerland |
| Cunningham, Craig (Maine Manufacturing 2007– Founder + VP Engineering + Development) | Research & Development Manager | GVS (IT) (Group) | United States (USA) |
| Cunningham, David (Royal Marsden Hospital 200909 Head Gastrointestinal Unit) | Professor | United Kingdom (GB) (govt) | United Kingdom (GB) |
| Currie, Ed (SIRS-Lab 200902– Executive VP Corp Development before Kuros BioSurgery before Lilly + Roche + IBM) | Business Development Manager / Strategy Manager | Endress+Hauser (Group) | Germany |
| Curtin, Francois (Geneuro 201207 CEO) | Chief Executive Officer (CEO) | GeNeuro S.A. (Euronext Paris: GNRO) | Switzerland |
| Curtis, Andrew (Affimed 201512– before Pfizer 2008– 2014 Head Corporate Strategy + BusDev before Jerini US + Genzmye) | Business Development Manager / Strategy Manager | Affimed (Group) | United States (USA) |
| Curtis, Michael (Cadent Therapeutics 201811 CEO) | Chief Executive Officer (CEO) | Cadent Therapeutics (US) | United States (USA) |
| Curvers, Simon (Direvo 201101– Director R&D before at Direvo since 200711 + AC Biotech 200101–200905 Managing Director) | Research & Development Manager | Direvo Industrial Biotechnology (Group) | Germany |
| Cuss, Francis (BMS 201410 EVP + CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Bristol-Myers Squibb (BMS) (Group) | United States (USA) |
| Cuypers, Heinrich (BioCon Valley 201105 Senior Project Manager) | n. a. | BioCon Valley GmbH | Germany |
| Czerepak, Elizabeth A. (Isarna Therapeutics 201404– CFO/CBO based in US before Bear Stearns Health Innoventures) | Chief Financial Officer (CFO) | Bear Stearns (Group) | United States (USA) |
| Czerney, Peter (Dyomics 200301 Managing Director + Founder) | Managing Director | Dyomics GmbH | Germany |
| Dabrowski, Michael (Pelago Bioscience AB 201506 CEO) | Chief Executive Officer (CEO) | Pelago Bioscience AB | Sweden |
| Dabrowski, Tomasz (Dentons 201412 Europe CEO) | Chief Executive Officer (CEO) | Dentons (Group) | Switzerland |
| Dabu, Ferdinand (SGS 201011 Global Marketing Director Life Sciences Services R&D/QC) | Sales Manager / Marketing Manager | SGS (Group) | Switzerland |
| Dadswell, Charles (Illumina 201604 SVP + General Counsel) | General Counsel / Chief Legal Officer (CLO) | Illumina (Group) | United States (USA) |
| Daglinger, Birgit (Ferring 201210 Managing Director of Ferring Arzneimittel GmbH) | Managing Director | Ferring (Paulsen Foundation) (Group) | Germany |
| Dahiyat, Bassil (Xencor 200607 President + CEO) | Chief Executive Officer (CEO) | Xencor Inc. (Nasdaq: XNCR) | United States (USA) |
| Dahlhauser, Eric B. (Insight Genetics 201201 CEO before Genetics Assays CEO) | Chief Executive Officer (CEO) | Insight Genetics Inc. | United States (USA) |
| Dahlstroem, Christina (Epigenomics) | n. a. | Epigenomics (Group) | Germany |
| Dahmen-Levison, Ursula (Aokin AG 201104 CEO) | Chief Executive Officer (CEO) | Aokin AG | Germany |
| Dallas, Jayson (Aimmune Therapeutics 201806– CEO before Ultragenyx + Roche + Novartis + Pfizer + P&G Pharma) | Chief Executive Officer (CEO) | Aimmune Therapeutics (Group) | United States (USA) |
| Dalle Carbonare, Bruno H. | n. a. | University of Basel | Switzerland |
| Dallmann, Isabel (Apogenix 200603) | n. a. | Apogenix GmbH | Germany |
| Damgaard-Iversen, Karsten (Humedics 201705– CEO before Toshiba Europe + SonoCine + Fisher Imaging + Storz Medical) | Chief Executive Officer (CEO) | Humedics GmbH | Germany |
| Daminger, Dieter (BioPark Regensburg 201104 Managing Director) | Managing Director | Regensburg (govt city) | Germany |
| Damour, Bertrand (OncoEthix 201101– CEO before Egalet CFO + GeneProt CEO + CFO + JP Morgan London) | Chief Executive Officer (CEO) | Merck (US) (MSD) (Group) | Switzerland |
| Dancer, Jane (F-Star 201205– COO before Cellzome 200801– VP BusDev before CAT) | Chief Operating Officer (COO) | F-Star (Group) | United Kingdom (GB) |
| Dandekar, Thomas | n. a. | University of Würzburg | Germany |
| Dangl, Markus (Medigene 201603– SVP Research + Pre-Clinical Development before Roche Diagnostics GmbH) | Research & Development Manager | Medigene (Group) | Germany |
| Danhauser-Riedl, Susanne (4SC 201401– CMO before GSK GmbH + MedacSchering Onkologie GmbH) | Chief Medical Officer (CMO) | 4SC (Group) | Germany |
| Daniel, Hannelore (TU Munich 200608 Prof) | Professor | Technical University Munich (TU München, TUM) | Germany |
| Daniel, Rolf (Univ Göttingen 201311 Professor) | Professor | Norddeutsches Zentrum für Mikrobielle Genomforschung (NZMG) | Germany |
| Daniell, Wayne (NanoScape AG 201102 CEO) | Chief Executive Officer (CEO) | NanoScape AG | Germany |
| Daniels, Graeme (Andrew Alliance 201809– VP Business Development before ADInstruments + Cytocentrics + Tecan UK) | Business Development Manager / Strategy Manager | Andrew Alliance (Group) | Switzerland |
| Danne, Doug (Lonza 201010 Head Rapid Testing Solutions business unit) | President/Director/Head Business Group/Unit/Division | Lonza Group (Group) | Switzerland |
| Dannenberg, Jens (Qiagen 200706 Global Product Manager) | Product Manager (personnel) | Qiagen (Group) | Germany |
| Danner, Stefan (Maiwald Patentanwalts-GmbH 200809 patent attorney) | Patent Attorney | Maiwald Patentanwalts GmbH (Munich) | Germany |
| Dannfeld, Robert (Pharmatio GmbH 201708 Managing Director) | Managing Director | Pharmatio GmbH | Germany |
| Dansky, Peter M. (Agena Bioscience 201407– CEO before Life Technologies + Applied Biosystems + Arcturus + Affymetrix) | Chief Executive Officer (CEO) | Thermo Fisher (Group) | United States (USA) |
| Danzl, Michael (Actelion 201606 General Manager at Actelion Germany) | General Manager (management) | Johnson & Johnson (JnJ) (Group) | Germany |
| Darbouret, Bruno (Thermo Fisher 201109 Director RnD BRAHMS Biomarkers) | Research & Development Manager | Thermo Fisher (Group) | Germany |
| Darr, William (ADF/IDF 201901 Founder) | Company Founder | Symrise (Group) | United States (USA) |
| Dartsch, Stefan (Ionovation 201206 Managing Director) | Managing Director | Ionovation GmbH | Germany |
| Dasberg, David (Facio Therapies 201504 Managing Director) | Managing Director | Facio Therapies B.V. | Netherlands |
| Datla, Vijay Kumar (Biological E 201109 Managing Director) | Managing Director | Biological E. Ltd. | India |
| Datta, Merrilyn (Definiens 201304– Chief Marketing Officer based in Carlsbad, CA before Life Technologies) | Sales Manager / Marketing Manager | AstraZeneca (Group) | United States (USA) |
| Daub, Achim (Symrise 201404 Global President Scent + Care) | President/Director/Head Business Group/Unit/Division | Symrise (Group) | Germany |
| Daub, Henrik (MPI for Biochemistry 200603) | n. a. | Max Planck Society for the Advancement of Science | Germany |
| Dauer, Ulrich (Probiodrug 201805– CEO before Omeicos + Activaero + 4SC + Tripos) | Chief Executive Officer (CEO) | Probiodrug (Group) | Germany |
| Daujotyte, Dalia (Lexogen 201806 Head of Business Development) | Business Development Manager / Strategy Manager | Lexogen GmbH | Austria |
| Daum, Dieter (Sony 201203 CEO of Sony DADC) | Chief Executive Officer (CEO) | Sony (Group) | Austria |
| Dausend, Melanie (Univ Wuppertal 201005 Analytical Service Mass Spectrometry) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | University of Wuppertal | Germany |
1 2 3 ... 10 11 12 ... 65 66 67
Advertisement
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
